HLA C Antibody (DT-9) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-50419PE
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Immunoprecipitation
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # DT-9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Purified tamarin MHC class I molecules (using anti-class I antibody BB7.7)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for HLA C Antibody (DT-9) [PE]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: HLA-C
Long Name
Major Histocompatibility Complex, Class I, C
Alternate Names
D6S204, HLA-JY3, HLAC, HLC-C
Gene Symbol
HLA-C
Additional HLA-C Products
Product Documents for HLA C Antibody (DT-9) [PE]
Product Specific Notices for HLA C Antibody (DT-9) [PE]
This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...